Medical research
Another promising approach for hard-to-treat blood cancers
For patients with some hard-to-treat blood cancers, a simple "off-the-shelf" immunotherapy is achieving promising results.
Apr 7, 2021
0
7
Page 35 - News tagged with car
Oncology & Cancer
Stem cell transplants prevent relapses of most common childhood cancer
Children and young adults who receive CAR T-cell therapy for the most common childhood cancer, acute lymphoblastic leukemia, suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired ...
Apr 1, 2021
0
6
Pediatrics
Parents often don't use child car seats in ride-share
A national survey of parents revealed that most parents who used ride-share services did so with their children, but only half of the respondents reported that children who were 8 years or younger traveled in the recommended ...
Mar 29, 2021
0
5
Immunology
Researchers use mathematical modeling to analyze dynamics of CAR T-cell therapy
Chimeric antigen receptor T-cell therapy, or CAR T, is a relatively new type of therapy approved to treat several types of aggressive B cell leukemias and lymphomas. Many patients have strong responses to CAR T; however, ...
Mar 25, 2021
0
4
Neuroscience
Doubling down on headache pain
It's not uncommon for people who experience a concussion to have moderate to severe headaches in the weeks after the injury. A new study has found a combination of two drugs, both common anti-nausea medications, given intravenously ...
Mar 24, 2021
0
0
Oncology & Cancer
Engineered safety switch curbs severe side effects of CAR-T immunotherapy
UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor T-cell (CAR-T) therapy, a type of immunotherapy, to reduce the ...
Mar 4, 2021
0
6
Pediatrics
Hassles with child car seats linked to unsafe child passenger behaviors
Parents who reported more hassles using a child car seat or booster seat—such as the child is uncomfortable or having to make multiple trips in a day—were less likely to follow recommendations from the American Academy ...
Mar 3, 2021
0
3
Oncology & Cancer
CAR T-cell therapy generates lasting remissions in patients with multiple myeloma
In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has generated deep, sustained remissions in patients who had relapsed from several previous therapies, an international clinical trial has found.
Feb 25, 2021
0
24
Oncology & Cancer
CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five years after receiving the chimeric antigen receptor (CAR) T cell therapy Kymriah, researchers ...
Feb 18, 2021
0
12
Diseases, Conditions, Syndromes
Researchers learn what's driving 'brain fog' in people with COVID-19
One of the dozens of unusual symptoms that have emerged in COVID-19 patients is a condition that's informally called "COVID brain" or "brain fog." It's characterized by confusion, headaches, and loss of short-term memory. ...
Feb 9, 2021
0
7
